Gelonghui September 12th 丨Yingjian Healthcare (01419.HK) announced that for the year ended June 30, 2023, it is expected to record no more than HK$185 million in profit attributable to company owners. Comparatively, for the year ended June 30, 2022, the profit attributable to company owners was approximately HK$375.3 million.
According to the announcement, the decrease in profit attributable to company owners in the year was mainly due to (i) reduced demand for COVID-19 related prevention, testing, vaccination and outreach services; (ii) reduced gross profit due to a decrease in general medical service revenue; (iii) net change in fair value of group financial assets and investment properties, which included profit and loss at fair value, from net fair value income of approximately HK$26 million in the previous year to net fair value recorded losses for the year; and (iv) the increase in property, plant and equipment depreciation.